Home › Congenital Heart Defects › NCT00556530
Examining Genetic Factors That Affect the Severity of 22q11.2 Deletion Syndrome
RecruitingObservational study
Genetic Modifiers of 22q11.2 Deletion Syndrome
Who can join
All ages · All sexes
Full eligibility criteria
Inclusion Criteria: * Has 22q11 deletion of 3 megabases (Mb) Exclusion Criteria: * Has 22q11 deletion smaller than 3 Mb or no deletion
About the study
22q11.2 deletion syndrome is a genetic disorder that can cause heart defects, facial abnormalities, and developmental and learning disabilities. The severity of the disorder can vary widely among people. This study will analyze DNA from people with 22q11.2 deletion syndrome to identify genetic variations that may affect the severity of the disorder.
Sponsor: Albert Einstein College of Medicine · Participants: 1,000 · Started: 2016-07
Contact the study team
- Bernice E. Morrow, PhD · Phone: 914-329-4653
Official record on ClinicalTrials.gov — NCT00556530
Locations in the U.S.
| New York | Albert Einstein College of Medicine, New York |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.